Pivotal Study of the Al-Sense Study Protocol

Amniotic Fluid Leakage Clinical Trial

Official title:
Pivotal Study of the Al-ASense Study Protocol

Status Completed

Clinical Trial Summary

The purpose of this study is to demonstrate that the Diagnostic Absorbent Panty liner (AL-SENSE Amniotic Leak Test Kit), developed by Common Sense Ltd., can distinguish between wetness sensed by pregnant women that is caused by amniotic fluid leakage and that which is caused by urinary incontinence.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Amniotic Fluid Leakage

Clinical Trial Details

NCT number	NCT00604838
Study type	Interventional
Source	Western Galilee Hospital-Nahariya
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	May 2006
Completion date	November 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04963465` - The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
Completed	`NCT04100252` - The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes
Completed	`NCT03190434` - Pivotal Study of the AL-SENSE in Diagnosis Amniotic Fluid Leakage	N/A
Active, not recruiting	`NCT01517633` - Study of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine	Phase 2/Phase 3